Capital Building in Washington DC

Advocacy & Policy

To improve patient care, ASCO advocates for increased federal funding for research, greater health care access, value in cancer care, and payment reform.

  • ASCO Examines U.S. Oncology Clinical Pathways Landscape

    ASCO has released its review of leading oncology pathway vendors in the United States. The assessment, published in the Journal of Oncology Practice, examines the clinical pathways offered by six commercial vendors using the society’s criteria for high-quality clinical pathways.

    Read More
  • Congressional Budget Deal Addresses Key Cancer Policy Issues

    Congress passed the “Bipartisan Budget Act of 2018,” which funds the federal government through March 23, 2018, raises the federal budget caps for the next two years, and addresses several policies of importance to the cancer community.

    Read More
  • New ASCO in Action Podcast Episode on Congressional Advocacy

    2017 ASCO Advocate of the Year, Dr. Robin Zon, joined ASCO CEO Dr. Clifford Hudis to discuss Congressional advocacy and the role it plays in shaping cancer-related policies on the latest ASCO in Action Podcast episode.

    Listen Now

Random Quote

"At ASCO, there's a place for everyone from every corner of oncology and the world."
Allen S. Lichter, MD, FASCO
ASCO CEO 2006-2016